1 October 2022
Linklaters advises GENFIT on the acquisition of Swiss biopharmaceutical company Versantis AG
Advising firms
Deal team
7 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Pierre Thomet Lead | Linklaters | Partner | Corporate/M&A | Paris |
| Julien Bourmaud-Danto | Linklaters | Counsel | Corporate/M&A | Paris |
| Géraldine Gonzalvez | Linklaters | Associate | Corporate/M&A | Paris |
| Bertrand Sénéchal | Linklaters | Partner | Capital Markets | Paris |
| Antoine Galvier | Linklaters | Associate | Capital Markets | Paris |
| Géric Clomes | Linklaters | Partner | Employment Law | Paris |
| Valentine Charrier | Linklaters | Associate | Employment Law | Paris |
4 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- GENFITBuy-side
- Counterparties
- Versantis (Sell-side)